| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1022783085 |
| P356 | DOI | 10.1007/S12149-015-0964-8 |
| P698 | PubMed publication ID | 25801633 |
| P2093 | author name string | Ming Jiang | |
| Xin Zhang | |||
| Rong Tian | |||
| Chong Jiang | |||
| Minggang Su | |||
| Liqun Zou | |||
| Russell Oliver Kosik | |||
| P2860 | cites work | Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia | Q30680953 |
| Standards for PET image acquisition and quantitative data analysis | Q33432463 | ||
| 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation | Q33606294 | ||
| PET and restaging of malignant lymphoma including residual masses and relapse | Q35128264 | ||
| Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma | Q36715057 | ||
| PET and PET/CT for response evaluation in lymphoma: current practice and developments | Q36746441 | ||
| The role of FDG-PET scans in patients with lymphoma | Q36914696 | ||
| Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. | Q37625441 | ||
| Treatment of localized extranodal NK/T cell lymphoma, nasal type | Q37810526 | ||
| Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma | Q43885591 | ||
| Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma. | Q45849759 | ||
| Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center. | Q53066391 | ||
| Prognostic value of interim and posttherapy 18F-FDG PET/CT in patients with mature T-cell and natural killer cell lymphomas. | Q53116295 | ||
| 18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group. | Q53276101 | ||
| P433 | issue | 5 | |
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | 442-451 | |
| P577 | publication date | 2015-03-24 | |
| P1433 | published in | Annals of Nuclear Medicine | Q15766511 |
| P1476 | title | Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type | |
| P478 | volume | 29 |
| Q90260579 | PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues |
| Q57453615 | Positron emission tomography/computed tomography in the diagnosis, staging, and prognostic evaluation of natural killer/T-cell lymphoma |
| Q37702163 | Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma |
| Q37602246 | Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase. |
| Q38410048 | Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma |
| Q89933345 | [Value of PET-CT clinical application in extranodal NK/T cell lymphoma] |
Search more.